Evaluation of Mechanical Stapler for Aortic Anastomoses
NCT ID: NCT00319475
Last Updated: 2006-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2006-02-28
2006-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AAA or AF/IB (end-to-end) in patients with Leriche Syndrome
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is diagnosed with Abdominal Aortic Aneurysm (AAA) or -aorto-Iliac/Femoral Occlusive Arterial Disease (Leriche' syndrome) by CT-Angio examination and/or angiography examination in patients with Leriche' syndrome.
* Patient with an aneurysm at the neck of the proximal or distal site that is between 5 to 10 mm and with a diameter of 16-22 mm.
* Patient is scheduled for AAA repair
Exclusion Criteria
* Active malignancy
* Ruptured aneurysm
* Thoraco-AAA
* Patient with at least one of the following unstable risk factors:
* Renal disease (Cr \>2)
* Ischemic heart disease (unstable Angina)
* Obstructive Pulmonary Disease (contraindicated for open aortic surgery by respiratory function exam)
* Severe CHF (EF \< 25%)
* Patient with known allergy to metals or to the contrast media
* Participation in current or recent (within 60 days prior to surgery) clinical trial
21 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SVSE 2000 Ltd.
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ralf Kolvenbach, MD
Role: PRINCIPAL_INVESTIGATOR
Augusta Hospital, Berlin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Augusta Hospital
Düsseldorf, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EU-DE 006
Identifier Type: -
Identifier Source: org_study_id